Hanna Janke

517 citations
4 papers · 136 indexed · h-index 3
Topics
Acute Myeloid Leukemia Research (3 papers)Chronic Myeloid Leukemia Treatments (2 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers)
Partner nations
GermanyNew Zealand

In The Last Decade

Hanna Janke

4 papers receiving 136 citations

Peers

Hanna Janke
Comparison fields: 5 of 16
  • Hematology 127
  • Molecular Biology 69
  • Genetics 48
  • Public Health, Environmental and Occupational Health 31
  • Cancer Research 13
Replace Claudia Haferlach with:
Claudia Haferlach Germany
M. F. McMullin United Kingdom
Mélanie Da Costa France
Farhad Ravandi United States
S. Schnittger Germany
Kristen Meldi United States
Konstandina Isaakidis Germany
Maxime Bucci France
Kristin L Koenig United States
Tomoaki Kitano Japan
Hanna Janke relative to Claudia Haferlach Germany Claudia Haferlach's profile →
Citations per field
00.5×10×15×
Claudia Haferlach · 1×
Citations per year

Countries citing papers authored by Hanna Janke

Since Specialization
Citations

This map shows the geographic impact of Hanna Janke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Janke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Janke more than expected).

Fields of papers citing papers by Hanna Janke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Janke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Janke. The network helps show where Hanna Janke may publish in the future.

Co-authorship network of co-authors of Hanna Janke

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Janke. A scholar is included among the top collaborators of Hanna Janke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Janke. Hanna Janke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 76
2 1
3 50
4 9

About Hanna Janke

Hanna Janke is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 4 papers that have together received 136 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (127 citations), Genetics (48 citations) and Public Health, Environmental and Occupational Health (31 citations). Hanna Janke has collaborated with scholars based in Germany and New Zealand. Frequent co-authors include Karsten Spiekermann, Stefan K. Bohlander, Tobias Herold, Wolfgang E. Berdel, Marion Subklewe, Wolfgang Hiddemann, Harald Polzer, Nikola P. Konstandin, Dennis Göerlich and Bianka Ksienzyk. Their work appears in journals such as PLoS ONE, Haematologica and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026